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Objectives: It is not known whether anormal diffusing capacity for carbon monoxide permits afe lung 
resection in patients with marginal spirometric values, or whether normal spirometric values negate 
the adverse ffects of a low diffusing capacity. The purposes of this study were (1) to determine the 
best predictors of morbidity and mortality and (2) to assess whether interactions exist between 
diffusing capacity and spirometry that help estimate outcome after major lung resection. Design: A 
retrospective analysis of 376 patients who underwent lung resection was performed. Three hundred 
three had lung cancer and 73 had other disease. Two hundred eighty-four underwent lobectomy/ 
bilobectomy and 92 had pneumonectomy. Weassessed the relationship of 23 preoperative ariables 
to 18 postoperative events classified into categories as pulmonary or cardiac complications, overall 
morbidity, and operative mortality. Results: The best single predictor of complications was the 
percent predicted postoperative diffusing capacity. The incidences of pulmonary and cardiac 
complications, morbidity, and mortality were inversely related to predicted postoperative diffusing 
capacity percent (p < 0.004 for each). Multivariate logistic regression analyses identified only 
predicted postoperative diffusing capacity percent and age as significant independent predictors of 
pulmonary complications, morbidity, and death, and these with prior myocardial infarction 
predicted cardiac omplications. There were no interactions between percent predicted postoperative 
forced expiratory volume in 1 second and predicted postoperative diffusing capacity percent in 
estimating risks of complications. Conclusion: Predicted postoperative diffusing capacity percent is 
the strongest single predictor of risk of complications and mortality after lung resection. There is 
little interrelationship of predicted postoperative diffusing capacity percent and predicted postop- 
erative forced expiratory volume in 1 second, indicating that these values should be assessed 
independently in estimating operative risk. (J THORAC CARDIOVASC SURG 1995;109:275-83) 
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Operat ive  risk for lobectomy and pneumonec- 
tomy is traditionally estimated by assessment of 
cardiac function, evaluation of spirometric measure- 
ments, and analysis of arterial blood gas values. 
Only moderate correlations have been reported 
between any of these variables and the prevalence of 
complications after lung resection, l' 2 The diffusing 
capacity of the lung for carbon monoxide (DLco) 
recently has been shown to be an independent 
predictor of operative morbidity and mortality after 
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Table I. Preoperative and operative factors 
examined in evaluating risk of pulmonary resection 
General 
Year of operation 
Age 
Sex 
Diagnosis 
Stage (where applicable) 
Diabetes mellitus 
Serum creatinine 
Cardiopulmonary, qualitative 
NYHA class 
Hypertension 
Prior myocardial infarction 
Tobacco use 
Cardiopulmonary, quantitative 
FVC, FVC% 
FEV1, FEV1%, ppoFEV1, ppoFEV1% 
DLco, DLco%, pp0DLco, ppoDLeo% 
ppoPROD 
Extent of resection 
NYHA, New York Heart Association; FVC, forced vital capacity; FEV1, 
forced expiratory volume in 1 second; DLco, diffusing capacity for carbon 
monoxide; See text for explanation f pulmonary function test values 
expressed asa percent of predicted normal nd for calculation f predicted 
postoperative (ppo) values and product (ppoPROD). 
Table II. Categories of postoperative events 
evaluated in estimating risk of pulmonary resection 
Death 
Morbidity 
Pulmonary 
Postoperative ntilatory support >24 hours 
Reintubation 
New bronchodilator use 
Pneumonia 
Lobar collapse 
Cardiac 
Myocardial infarction 
New/3-adrenergic blocker use 
Vasodilator administration 
Inotropic support 
Arrhythmia 
Other 
Wound infection 
Empyema 
Air leak >7 days 
Pulmonary embolus 
Bronchopleural fistula 
Recurrent laryngeal nerve injury 
Miscellaneous 
major pulmonary resection)'  4 The use of this mea- 
surement as a preoperative screening tool has not 
been widespread. It is not known whether normal 
DLco permits safe resection in patients with mar- 
ginal spirometric values or whether normal spiro- 
metric values negate the adverse effects of a low 
diffusing capacity. The purposes of this study were to 
determine the best predictors of risk of morbidity 
and mortality after major lung resection and to 
assess whether interactions exist between DLco and 
spirometry that help estimate outcomes after major 
lung resection. 
Patients and methods 
A retrospective r view was conducted of the records of 
406 patients who underwent lobectomy, bilobectomy, or 
pneumonectomy at the University of Chicago Medical 
Center from January 1980 through December 1992. Thirty 
patients were excluded from analysis because they had 
undergone urgent thoracotomy for trauma or prior lung 
resection. The analysis was performed on the remaining 
376 patients. Data were recorded for 23 preoperative and 
operative risk factors (Table I). Spirometry and measure- 
ment of total lung capacity and DLco were performed as 
previously described." Normal values for lung volumes 
were taken from regression equations of Morris, Koski, 
and Johnson (men) 5 and Goldman and Becklake (wom- 
en). 6 Prediction equations for DL~o were those of Gaens- 
ler and Wright. 7 Diffusing capacity was corrected for 
hematocrit value, and the results were corrected further 
for lung volume by the equation of Gelb and associates, s 
Predicted postoperative function was calculated for the 
forced expiratory volume in 1 second (FEV1) and DLco 
(ppoFEVa, ppoDL¢o ) and for FEV1 and DLco expressed 
as a percent of predicted normal values (ppoFEVl%, 
ppoDI.co% ) by multiplying the raw values or percent of 
predicted normal values of observed measurements by the 
fraction of functional lung segments remaining after re- 
section. Functional lung segments were assigned as calcu- 
lated previously 9'lo: right upper lobe 3; right middle lobe 
2; right lower lobe 5; left upper lobe 5; left lower lobe 4. 
The product of ppoDLco and ppoFEV1 was calculated 
(ppoPROD)J 1 Data on 18 postoperative complications 
were recorded as previously defined. 3
Descriptive summary statistics were produced to char- 
acterize the 376 cases in terms of baseline variables. Five 
binary outcome variables (present/absent) were con- 
structed on the basis of operative complications: mortality 
(death during hospitalization for operation or within 30 
days of operation), pulmonary, cardiac, other, and overall 
morbidity (an aggregation ofall complications) (Table II). 
In cases in which patient outcome data could not be 
scored reliably, the outcomes were classified as missing. 
Univariate associations with each of the five outcome 
variables were performed by means of contingency table 
analyses (X 2 test) for categoric predictive variables and 
Student's t tests for continuous predictive variables. 12 
Because of the exploratory nature of this retrospective 
study and the multiple statistical tests performed, the 
significance of the results was interpreted with caution. 
Two-sided significance l vels less than 0.05 were deemed 
to be of modest statistical significance. Significance levels 
less than 0.001 were judged to be highly significant and 
worthy of clinical consideration. 
Recoding of three continuous measures (ppoFEV1%, 
ppoDLco%, and ppoPROD) was used to create ordinal 
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categoric variables. These were correlated with each of the 
five outcome variables by either an exact or an asymptotic 
computation of the Cochran-Armitage trend test for a 
one-sided alternative (i.e., P1 -> P2 ->... -> Pn, where P, 
denotes the proportion of patients with the complication i
the nth level of the categorized variable). 13 
Forward stepwise logistic regression was performed to 
identify variables that were significant and independent 
predictors of each particular type of complication. 14Like- 
lihood ratio tests were used to determine significance. 
Because of both the large number of predictor variables 
that were considered and the extent of missing data for 
some variables, the pool of candidate covariates for 
stepwise regression was carefully selected on the basis of 
the significance of the univariate results across all five 
outcomes. To avoid problems with multicollinearity 
among the pulmonary function measurements, we con- 
structed three pools of covariates that included both 
measured preoperative and estimated postoperative al- 
ues expressed as (1) raw values (FVC, DLco , FEV1, 
ppoDLco , ppoFEVa), (2) percent of predicted normal 
values (FVC%, DLco% , FEV1%, ppoDL¢o, ppoFEV1% ), 
or (3) a combination of these (FVC, DEc° , FEV1, 
ppoPROD). Each group was tested separately. Four of 
the 10 baseline patient variables (age, sex, New York 
Heart Association score, and prior myocardial infarction) 
were selected to be included in these pools of covariates 
on the basis of univariate correlations. 
All data checking, descriptive statistics, )(2 tests, Stu- 
dent's t tests, and stepwise logistic regression analyses 
were performed in Number Cruncher Statistical System 
(NCSS, Jerry Hintze, Kaysville, Utah). All exact and 
asymptotic Cochran-Armitage tr nd tests were performed 
in StatXact (CYTEL Software, Cambridge, Mass.). 
Results 
The group comprised 221 men and 155 women 
with a mean age of 60 years (median 62 years, range 
17 to 87 years). There was a smoking history in 339 
patients (90%), 44 (12%) had diabetes, 110 (29%) 
had hypertension, and 10% (14/134) had a serum 
creatinine concentration greater than 1.4 mg/dl. The 
majority of patients (358/369; 97%) were in New 
York Heart Association class I or II, 3% (11/369) 
were in class III, and none were in class IV. Forty- 
seven (13%) patients had a history of prior myocar- 
dial infarction, none of which had occurred in the 3 
months before resection. Spirometric values, diffus- 
ing capacity measurements, he predicted postoper- 
ative values for these determinations, and the cal- 
culated ppoPROD are listed in Table IlL 
Operations performed were lobectomy (246; 
65%), bilobectomy (38; 10%), and pneumonectomy 
(92; 25%). Three hundred three patients (80%) 
underwent resection for lung cancer, of whom 128 
had stage I disease, 55 were stage II, and 119 stage 
IIIA-B. The stage was unknown in one patient. 
Twenty patients had resection for metastatic disease, 6
Table III. Pulmonary function data* 
Predicted 
Preop. postop. 
value value 
FVC (L) 3.25 _+ 0.92 - -  
FVC% 86.3 _+ 18.1 - -  
FEV 1 (L) 2.29 _+ 0.71 1.64 _+ 0.63 
FEV1% 83.7 + 20.7 61.0 + 20.0 
DLco (ml/min/torr)  20.5 _+ 6.3 14.8 _+ 5.3 
DLco% 86.3 +-- 21.8 62.1 --+ 18.5 
ppoPROD - -  4014 -+ 2052 
For abbreviations see Table I. 
*Values are mean -+ standard eviation. 
for carcinoid tumor, and 47 for benign problems. The 
prevalence of complications i listed in Table IV. 
Information regarding complications other than death 
was not available for all patients. The hospital mortal- 
ity rate for major pulmonary resection in patients with 
lung cancer was 7.6%. The mortality for those under- 
going lobectomy or bilobectomy was 5.6% and was 
12.5% for pneumonectomy. Pulmonary complications 
occurred in 20.1% (60/298), cardiac complications in
22.6% (65/287), and other complications in 33.1% 
(96/290), for an overall morbidity of 48.3% (141/292) 
in patients with lung cancer. 
Univariate analysis demonstrated that age, sex, 
New York Heart Association class, and prior myo- 
cardial infarction were the only demographic vari- 
ables that were at least of moderate statistical 
significance (p < 0.05) as predictors of morbidity 
and/or mortality. In contrast, the preoperative and 
predicted postoperative alues for all of the pulmo- 
nary function tests except FVC% were statistically 
significant predictors of most of these complications 
(Table V). Logistic regression used to test the 
univariate models demonstrated that the best single 
predictor of mortality was ppoDLco%. The inci- 
dences of mortality and other complications (pul- 
monary, cardiac, overall morbidity) were inversely 
related to ppoDLoo% (Cochran-Armitage trend test; 
Fig. 1). According to the percent predicted covariate 
pool described earlier, stepwise logistic regression 
analysis identified only ppoDLco% and age as pre- 
dictors of pulmonary complications (t9 < 0.0001), 
morbidity (p = 0.0005), and mortality (p < 0.0001), 
and these along with a history of prior myocardial 
infarction predicted cardiac morbidity (p < 0.0001) 
(see appendix). 
The respective contribution of ppoFEV1% and 
ppoDLco% to the prediction of mortality were ex- 
amined by constructing both a main effects model 
with only these variables and a main effects plus 
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Table IV. Morbidity and mortality after pulmonary resection (%) 
Lobectomy/bilobectomy Pneumonectomy Total 
No. % No. % No. % 
Mortality 18/284 6.3 11/92 12.0 29/376 7.7 
Morbidity 140/271 52 37/88 42 168/359 47 
Pulmonary 55/279 20 16/89 18 71/368 19 
Cardiac 52/264 20 23/86 27 75/350 21 
Other 94/269 35 23/88 26 117/357 33 
Table V. Results of univariate analysis* 
Morbidity 
Variable Mortality Pulmonary Cardiac Other Overall 
Operation year 0.41 0.10 0.76 0.017 0.03 
Age 0.13 0.85 0.02 0.92 0.02 
Sex 0.45 0.02 0.0002 0.97 0.77 
Diagnosis 0.59 0.69 0.55 0.37 0.34 
Stage 0.016 0.25 0.44 0.76 0.68 
Tobacco use 0.70 0.48 0.61 0.27 0.13 
Diabetes mellitus 0.30 0.11 0.82 0.58 0.67 
Hypertension 0.44 0.92 0.23 0.22 0.22 
Prior myocardial infarction 0.13 0.10 <0.0001 0.44 0.006 
NYHA class 0.02 0.016 0.01 0.75 0.37 
Serum creatinine 0.32 0.39 0.33 0.14 0.15 
FVC 0.09 0.003 0.23 0.08 0.02 
FVC% 0.29 0.19 0.09 0.49 0.42 
DLco 0.0004 <0.0001 0.016 0.02 0.0001 
DLco% 0.002 0.006 0.08 0.08 0.002 
FEV1 0.005 <0.0001 0.014 0.0011 0.0001 
FEV1% 0.22 0.013 0.02 0.06 0.05 
ppoDLco <0.0001 <0.0001 0.002 0.06 0.0002 
ppoDL¢o% <0.0001 0.0003 0.007 0.19 0.004 
ppoFEV1 0.0009 <0.0001 0.01 0.015 0.003 
ppoFEV1% 0.02 0.02 0.01 0.20 0.14 
ppoPROD 0.0006 0.0008 0.004 0.05 0.005 
*See Table I for definitions. 
interaction model including these variables and 
ppoPROD. In the two-variable model, only 
ppoDLco% was significant (p = 0.0013), whereas 
ppoFEV1% had no significant influence on mortal- 
ity (p = 0.70) (Fig. 2). In the interaction model 
ppoPROD was not a significant variable. These data 
indicate that there is little interaction between 
ppoFEVx% and ppoDLco in predicting mortality 
and that ppoDL~o% is the strongest single predictor 
of mortality after major lung resection. 
Discussion 
Despite the fact that the accurate stimate of risk 
of complications after major lung resection is vital, 
the use of traditional methods of assessing operative 
risk provides only a modest ability to predict post- 
operative morbidity and mortality)' 2Because many 
physicians find this extent of risk assessment insuf- 
ficient, others have investigated the utility of preop- 
erative exercise testing or measurement of physio- 
logic variables such as oxygen consumption and 
arterial oxygen saturation during exercise) 5-19 
These tests have not met with widespread use 
because they are expensive and labor intensive, and 
few data are available with which to assess their 
accuracy. In 1988 we 3 determined that the assess- 
ment of pulmonary gas exchange, expressed as 
preoperative single-breath DLco independently pre- 
dicts risk of mortality and pulmonary morbidity after 
lobectomy or pneumonectomy. Others confirmed 
these findings and suggested that the use of a 
postoperative predicted value of DLco (ppoDLco%), 
calculated by means of functional data from quan- 
titative ventilation/perfusion scans, offers an im- 
proved ability to predict such complications. 4 How- 
ever, it is unclear whether a normal diffusing 
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Fig. 1. The incidence of mortality (shaded bars), cardiac morbidity (open bars), pulmonary morbidity 
(cross-hatched bars), and overall morbidity (stippled bars) versus ppoDLco% (see text for explanation). Mortality 
and complications are inversely related to ppoDLco% (Cochran-Armitage trend test; p - 0.004 for each). 
capacity permits safe major lung resection in pa- 
tients with marginal spirometric values or whether 
an abnormal diffusing capacity suggests high opera- 
tive risk despite adequate spirometric values. Using 
data collected uring the generation of our original 
report, we have added information from patients 
operated on in the intervening years and performed 
a more rigorous statistical analysis of our data to 
address these questions. 
Our findings confirm those of our previous report 
that diffusing capacity is a strong and independent 
predictor of risk of mortality after major lung resec- 
tion. 3 In addition to its ability to estimate the risks of 
mortality and pulmonary morbidity, we also found 
that diffusing capacity was strongly predictive of 
cardiac complications and overall morbidity. The 
association of diffusing capacity and cardiac morbid- 
ity is not surprising because of the known increase in 
pulmonary vascular resistance that results from ma- 
jor lung resection. 2°' 21 All increase in pulmonary 
vascular resistance causes right heart strain, contrib- 
uting to the relatively high frequency of cardiovas- 
cular complications evident in our study and in 
reports by others. 22-24 The strong correlation be- 
tween ppoDLoo% and the overall risk of morbidity is 
likely due to the contribution of cardiopulmonary 
complications to overall morbidity. The lack of 
correlation between diffusing capacity and other 
complications that were unrelated to cardiopulmo- 
nary morbidity helps confirm its value in the physi- 
ologic assessment of patients considered for major 
lung resection. 
A strong correlation has been identified by others 
between predicted postoperative expiratory volumes 
(ppoFEVz and ppoFEVz%) and morbidity and 
mortality.4, 25-27 In contrast, all determinations of
FEV1 in our study, including preoperative and pre- 
dicted postoperative alues, were significant predic- 
tors of morbidity and mortality on univariate anal- 
ysis but failed to approach significance when joined 
with multiple variables during stepwise logistic re- 
gression analysis. There are many possible xplana- 
tions for this finding. Because of the retrospective 
nature of the study, patients were carefully selected 
before the operation, largely on the basis of 
ppoFEV1 (->900 ml) and, in recent years, ppoFEV1% 
(->40). In such a highly selected group, the predictive 
ability of FEV1 is substantially reduced. In addition, 
there is a statistical correlation between FEV1 and 
diffusing capacity, and some of the predictive ability of 
FEV~ may be duplicated by the inclusion of diffusing 
capacity values in the analysis. 
Our primary interest in performing this analysis 
was to determine whether anormal diffusing capac- 
ity permits afe resection i  patients with a marginal 
FEVa and whether a normal FEV1 negates the 
effects of a suboptimal diffusing capacity. Such a 
finding would have the potential effect of increasing 
the pool of individuals eligible for potentially cura- 
tive resection. It has been suggested by others that 
the product of ppoFEVz% and ppoDLco% , the 
so-called ppoPROD, may be a universal value that 
includes the important elements of both of  these 
measurements. H When combined with ppoFEV1% 
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Fig. 2. The probability of mortality expressed as a function of ppoDLco% and ppoFEV~%, where 
probability = 1/[1 + exp(-[0.703 - (0.0559 × ppoDLco% ) -- (0.00557 × ppoFEV1%)])]. Left, A surface 
constructed by calculating the estimated probability of mortality using ppoDL~o% and ppoFEV1% data 
from 287 patients. Actual operative mortalities are indicated by black dots. Right, A theoretical surface of 
predicted risk of mortality generated by the equation alone demonstrates that almost all of the risk is 
dependent on ppoDL~o%. 
and ppoDLoo% and subjected to stepwise logistic 
regression analysis, ppoPROD had no predictive 
power in our patient population. A similar analysis 
comparing ppoDLco% and ppoFEV1% determined 
that nearly all of the predictive power of these two 
variables was contained inppoDL~o%. As illustrated 
in Fig. 2, there is only a modest increment in the 
probability of mortality as ppoFEV1% declines, 
assuming ppoDLco% remains in a normal range. 
Conversely, as ppoDLco% decreases, mortality in- 
creases ubstantially, with little apparent influence 
of ppoFEV1%. These data indicate that there is no 
important interaction between ppoFEV1% and 
ppoDeco% in the prediction of risk of mortality 
after major lung resection and suggest hat each 
should be assessed independently in formulating 
recommendations regarding resection. 
From our data we were able to generate formulas 
that estimate the probabilities of mortality and 
pulmonary, cardiac, and overall complications for 
individual patients (see appendix). The specific 
equations developed from our patient data may not 
be directly applicable to other patient groups or 
individuals, however, and are provided only as sug- 
gested guidelines. 
It is important to remember that our conclusions 
are based on a retrospective analysis of patients 
operated on during a 13-year interval. There is no 
doubt that biases are reflected both in the patients 
who were referred for potential operation and in the 
selection of patients who eventually received an 
operation. Such biases are most strongly grounded 
in preoperative assessment of cardiovascular status 
and pulmonary function, the latter being based 
primarily on spirometry. Rather than using mea- 
surement of diffusing capacity to override selection 
bias based on these factors, we embrace their con- 
tinued use, because they have a proven record in 
predicting operative risk. However, dependence on 
spirometry alone in estimating the extent of pulmo- 
nary dysfunction is unreliable in many patients, 
particularly considering that many patients with lung 
cancer have a reduction of DLco that is out of 
proportion to changes in their spirometric values. 28 
We advocate the routine use of diffusing capacity 
assessment asan additional test that improves esti- 
mates of mortality and morbidity, both in an overall 
patient population and, potentially, in an individual 
patient. 
One of the authors (R.M.) was primarily responsible for 
the statistical nalyses included in this study. 
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Discussion 
Dr. Joseph I. Miller (Atlanta, Ga.). For those of us 
interested in the physiologic evaluation of the lung resec- 
tion candidate, I believe that this paper will become a 
major landmark in using values for resectability. 
There are several things I would like to mention. In the 
group of patients described by the authors, 75% under- 
went either lobectomy or bilobectomy and 25% under- 
went pneumonectomy, with mortality rates ranging from 
5.6% to 12.5% for the two groups, or a total of 7.7%. 
Several conclusions were reached from which I will 
ultimately raise several questions: First, the authors 
pointed out that there was little interreaction between the 
ppoFEV 1 and the ppoDLco in predicting mortality and 
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that the ppoDLco% was the strongest indicator of postop- 
erative morbidity and mortality. It is interesting that in 
their correlation there was no relationship between the 
FEVa, the FEVa%, and the estimated postoperative al- 
ues of these as identified as predictors of morbidity and 
mortality. Also, their primary interest was in performing 
an analysis to determine whether the DL~o would permit 
safe resection in patients with normal spirometric values 
or whether it is an adverse indicator despite normal 
values. 
In review of their manuscript, I would make the follow- 
ing statements: Block and Olsen in 1972 used a DLco of 
"greater than 50% of predicted" as one of the criteria for 
pneumonectomy. 
In a paper presented before the Association 2years ago, 
based on 2340 patients in whom spirometric values were 
applied to resection, these values were suggested as being 
the lower limits of normal below which a resection could 
be carried out. Again, in the lobectomy category there is a 
wide physiologic variable that will permit the majority of 
patients to undergo lobectomy when assessed carefully. In 
the pneumonectomy group the degree of variability that 
one can apply is much less. 
In that group of patients we looked also at DL~o, 
particularly in the pneumonectomy group. In the majority 
of those undergoing pneumonectomy, the preoperative 
DLco was greater than 50% of predicted, which went with 
the original criteria. 
I would raise the following questions for Dr. Ferguson; 
Do you believe there is a specific cutoff value of DL~o 
below which pneumonectomy should not be performed? 
Could you define a spectrum of parameters of DLco 
during which lobectomy could safely be carried out? Is 
there a DLco below which elective resection should not be 
carried out? 
A third statement that I would make is that the DLco is 
probably the most specific indicator in anticipating com- 
plications in the emphysematous l ng, particularly when 
combined with review of high-resolution computed tomo- 
graphic scanning. 
Dr. Ferguson. We have not separated out the effects of 
measuring diffusing capacity in predicting risk in patients 
undergoing lobectomy versus those undergoing pneumo- 
nectomy. Part of the value in measuring the ppoDL~o% is 
that it takes into account he amount of lung one is 
anticipating resecting. In general, at least on a mathemat- 
ical basis, one could use the same limiting value of 
ppoDL~o% in making a decision about patients being 
considered for lobectomy as one does in those being 
considered for pneumonectomy. However, that having 
been said, pneumonectomy is certainly a more morbid 
operation than lobectomy. Other factors are probably 
involved in determining morbidity and mortality in those 
patients in addition to simply the amount of lung that is 
resected. 
In looking at patients who have very acceptable FEVa 
values (one could take, for example, a postoperative 
predicted FEV 1 of 60%, which is well above the generally 
accepted limiting value of 40%), we find that the diffusing 
capacity is still a good predictor of mortality. For example, 
for patients with ppoDL~o% of less than 50, the mortality 
rate is about 15%, which compares with the whole group 
of patients with a ppoFEVa% greater than 60% in which 
the mortality rate is only about 3%. 
In general, we believe that a reasonable value to use for 
predicting high-risk patients is a ppoDLco% of 50. That is 
not a hard and fast rule. In fact, we will operate on 
patients who have predicted postoperative alues of less 
than 50. It is just an indicator that those patients are 
probably at higher risk. 
Dr. James B. D. Mark (Stanford, Calif.). You have 
made some presumptions, one of which is that the portion 
of lung that you are removing is functioning just as well as 
the portion of lung that you are leaving in. Thus you are 
using your preoperative predictors as predictors of post- 
operative function based on percentage of lung removed. 
Have you done any postoperative pulmonary function 
testing to either prove or disprove that preoperative 
presumption? 
Dr. Ferguson. We have not consistently tested these 
patients after the operation. In the studies in which 
postoperative t sts were done, the values sometimes do 
not correlate closely with the predicted values. Part of the 
reason for that is that in many patients the resected lung 
is not adequately functioning. In some patients there is 
airflow obstruction or decreased pulmonary artery flow to 
those lobes. Thus our estimates of ppoDLco%, in fact, turn 
out to be relatively conservative estimates. If one wishes to 
increase the accuracy of the estimate, quantitative vend- 
lation/perfusion scans help to determine how much func- 
tional lung is going to be removed. 
Appendix 
Multivariate analysis of risk factors influencing the 
development of pulmonary events, cardiac events, mor- 
bidity, or mortality was performed by means of stepwise 
logistic regression. With the formulas developed through 
this analysis, we report one optimal model for each of four 
categoric outcomes based on parsimony and the good- 
ness-of-fit X a statistic. Using these logistic regression 
models, we estimated the probability of mortality and 
other complications as a function of variables from the 
percent predicted postoperative alue covariate pool us- 
ing the logistic function: 
P(mortality) = 
1/(1 + exp[ - (BO + B1X1 + B2X2 + B3X3)]) 
where BO is a constant, B1 is the slope of the regression 
line describing the risk of mortality as a function of 
variable X1, B2 is the slope of the regression line describ- 
ing the risk of mortality as a function of variable X2, etc. 
On the basis of our data, 
LogitMortality = 
- 4.033 - (0.0767 X ppoDLco%) + (0.0852 X Age) 
and the probability of mortality for an individual is 
therefore calculated as 
eMortality 
1/(1 + exp[ - (-4.033 - [0.0767 X ppoDLco% ] 
+ [0.0852 x Age])]). 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 2 
Ferguson, Reeder, Mick 2 8 3 
0.60 
0.50 
0.40 
0.30 
0.20 
0.10 
0.00 
120 
0 
. i  
..Q 
0 t._ 
13. 
~ ~  0.60 
o.'o 
7- 0.30 
~ 0.20 
0 ~ ~ ~ 6 0  70 0"00 
60 5o 
B ~-o~ 100 120 20 30 
Appendix Fig. 1. The probability of mortality expressed as a function of ppoDLco% and age, where 
probability = 1/[1 + exp( - [ -4 .033  - (0.0767 × ppoDL~o% ) + (0.0852 X age)])]. Left, A surface 
constructed by calculating the estimated probability of mortality using ppoDL~o% and age data from 275 
patients. Actual operative mortalities are indicated by black dots. Right, A theoretical surface of predicted 
risk of mortality generated using the equation only demonstrates the interaction of ppoDL~o% and age in 
estimating risk. 
For example, assuming that a low-risk patient has 
ppoDLco% = 70 and age = 50 years, then 
PMo~taaty = 
1/(1 + exp[ - (-4.033 - [0.0767 X 70] + [0.0852 X 50])]) 
PMortality = 1/(1 + exp[ -- (--5.142)]), or 0.58% 
For moderate-risk patients who deviate from these rela- 
tively favorable values, the calculations are similar. For a 
patient with ppoDL~o% = 55 and age = 50 years, 
PMortality = 1/1(1 + exp[ - (--3.995)]), or 1.8%, 
and for a patient with ppoDL~o% = 70 and age = 65 years, 
PMortality = 1/(1 + exp[ -- (-3.864)]),  or 2%. 
Patients are at higher risk if they deviate further from the 
relatively favorable values. For example, for a patient with 
ppoDL~o% = 45 and age = 65 years, 
PMortality = 1/(1 + exp[--(-1.9465)]),  or 12.5%, 
and for a patient with ppoDL~o% = 55 and age = 75 years, 
PMortal i ty = 
1/(1 + exp[ - (-1.8615)]), or 13.5% (appendix Fig. 1). 
This formula also can be used to describe the increase 
in relative risk, or "odds," of mortality for a unit change in 
one variable, assuming that all other variables are held 
constant. For our data, a decrease in ppoDLco% of 10 
units (10%) is estimated to increase the odds of mortality 
by a factor of 2.15. The 95% confidence interval for this 
factor = exp[B(10) _+ 1.96 (standard error B)]. Since B = 
0.0767 -+ 0.0179 (standard error), the 95% confidence 
interval = 2.08 to 2.23. 
Similar equations developed for estimating the proba- 
bility of pulmonary morbidity, cardiac morbidity and 
overall morbidity are as follows: 
Logitpulmonary =
-2.408 - (0.0387 X ppoDLco%) + (0.0519 X Age) 
Logitfardiac = -2 .332-  (0.031 X ppoDLco%) 
+ (1.212 X Prior myocardial infarction) + (0.0406 x Age) 
Logitoverall morbidity = 
-0.228 - (0.0193 x ppoDLco%) + (0.0276 X Age). 
A statistically significant stepwise logistic regression 
model could not be constructed for predicting other 
complications. 
